Clinical Trials
2 trialsNCT02717091 2020-09-10
Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer
Nagoya University
Phase 2 Unknown
NCT03850769 2020-03-10
Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer
Peking Union Medical College Hospital
Phase 2 Unknown